Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Washington University School of Medicine
With
The Foundation for Barnes-Jewish Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Documentation of HBOC or Lynch-associated "pathogenic/ likely pathogenic" mutation per American College of Medical Genetics and Genomics criteria (1)
Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial
Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention
Over the age of 18
Psychological ability and general health that permits completion of study requirements and follow-up
Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months
You may not be if
"Variant of undetermined significance," "likely benign" or "benign" variant per ACMGG criteria
Clareo Health | Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
